Ergoteles LLC Elanco Animal Health Inc Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$11.49 - $13.65 $1.53 Million - $1.82 Million	-133,169 Reduced 90.96%	13,238 $161,000
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $226,085 - $590,627	18,218 Added 14.21%	146,407 $1.82 Million
Q2 2022 Aug 12, 2022	BUY	$19.63 - $26.62 $2.52 Million - $3.41 Million	128,189 New	128,189 $2.52 Million
Q4 2021 Feb 14, 2022	SELL	$27.74 - $34.09 $2.88 Million - $3.54 Million	-103,914 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $2.7 Million - $3.4 Million	92,514 Added 811.53%	103,914 $3.31 Million
Q2 2021 Aug 12, 2021	BUY	$28.76 - $35.98 $327,864 - $410,171	11,400 New	11,400 $395,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.